Shortfall in Phase-III Covaxin trial target, can delay rollout: AIIMS doctor
By Ashish Srivastava
New Delhi: The rollout of Covid-19 vaccine by Bharat Biotech for the general public may get delayed as the All India Institute of Medical Sciences (AIIMS), where its Phase-III human clinical trial is underway, is…